Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
The interleukin-1 receptor antagonist and its delivery by gene transfer.
C. H. Evans,
P. D. Robbins
Research output
:
Contribution to journal
›
Review article
›
peer-review
39
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The interleukin-1 receptor antagonist and its delivery by gene transfer.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Gene Transfer
100%
Interleukin-1 Receptor Antagonist (IL-1Ra)
100%
Interleukin-1β
70%
Interleukin-1 Receptor
20%
Activin Type II Receptor
20%
Clinical Trials
10%
Rheumatoid Arthritis
10%
Sepsis
10%
Biological Activity
10%
Asthma
10%
Human Disease
10%
Signal Transduction
10%
Chronic Disease
10%
Glycoprotein
10%
Chronic Myeloid Leukemia
10%
Alternative Splicing
10%
Biological Response
10%
Pharmacologic
10%
Cellular Response
10%
Pathophysiologic
10%
Gene Coding
10%
Decoy
10%
Affinity Constant
10%
Soluble Receptor
10%
Weak Affinity
10%
Spare Receptor
10%
Type I interleukin-1 Receptor
10%
Local Gene Delivery
10%
Systemic Gene Therapy
10%
IRAP
10%
Neuroscience
Interleukin 1 Receptor Antagonist
100%
Gene Transfer
100%
Interleukin 1
100%
Eicosanoid Receptor
42%
Cell Signaling
14%
Gene Delivery
14%
Alternative Splicing
14%
Rheumatoid Arthritis
14%
Interleukin-1 Receptor
14%
Agonist
14%
Glycoprotein
14%
Interleukin 1 Receptor Type I
14%
Receptor Reserve
14%
Interleukin 1 Receptor, Type II
14%
Pharmacology, Toxicology and Pharmaceutical Science
Interleukin 1
100%
Interleukin 1 Receptor Blocking Agent
100%
Receptor
42%
Disease
28%
Clinical Trial
14%
Biological Activity
14%
Chronic Disease
14%
Rheumatoid Arthritis
14%
Asthma
14%
Glycoprotein
14%
Chronic Myeloid Leukemia
14%
Interleukin 1 Receptor
14%
Receptor Reserve
14%
Interleukin 1 Receptor Type I
14%
Interleukin 1 Receptor Type II
14%
Gene Delivery
14%
Sepsis
14%